Employee Spotlight: Dennis John Powers – Go Health Pro

Employee Spotlight: Dennis John Powers – Go Health Pro

Here at Inszone, one of our missions is to make sure that every employee is appreciated, acknowledged, and recognized for their achievements. This Employee Spotlight series aims to celebrate success and highlight the talented individuals we have at Inszone, Cover Cannabis, and California Pool Association. Each month we’ll be featuring Inszone employees on our website, … Read more

Five astronomy activities for families around Paris – Go Health Pro

Five astronomy activities for families around Paris – Go Health Pro

Observing the vastness of the Universe, drawing a star map, pretending to be an astronaut on a mission, or watching a play – there are countless ways to be swept up among the planets. Let’s take a trip to infinity and beyond … The Musée de l’Air et de l’Espace at Le Bourget – Seine-Saint-Denis … Read more

EU Countries That Allow Dual Citizenship – Go Health Pro

EU Countries That Allow Dual Citizenship – Go Health Pro

Are you wondering which EU countries allow dual citizenship and how this can benefit you? For those who wish to maintain citizenship in more than one country, the rules can vary significantly across Europe. Some countries are more flexible, allowing dual nationality, while others have strict limitations.  In this blog, we’ll explore the countries that … Read more

Best Balance Transfer Cards Of November 2024 – Forbes Advisor – Go Health Pro

Best Balance Transfer Cards Of November 2024 – Forbes Advisor – Go Health Pro

You may be interested in pursuing a balance transfer no matter where you live, but there are a number of cities facing higher card balances than others. Credit card debt ballooned to a record $1.14 trillion nationwide in the second quarter of 2024, according to the Federal Reserve Bank of New York, but some cities … Read more

Germany’s BioNTech buys China’s Biotheus in US$800 million push into cancer drugs – Go Health Pro

Germany’s BioNTech buys China’s Biotheus in US0 million push into cancer drugs – Go Health Pro

BioNTech, the German developer of a widely used mRNA vaccine for the coronavirus, agreed to pay US$800 million (HK$6.24 billion) to buy biotech company Biotheus, a developer of cancer drugs. In a statement on Wednesday, Mainz-based BioNTech said it signed a definitive agreement to pay mostly cash for 100 per cent of Biotheus, which is … Read more

x